Komori
Changes in Officers177AKohjin Bio Co.,Ltd.Materials and Chemicals

Notice Regarding Changes in Representative Directors

Nakamura Takato (中村 孝人), Representative Director and President, changed to Representative Director and Chairman, while Nakamura Yuichi (中村 雄一), formerly a Senior Managing Director, changed to Representative Director and President. The company’s representatives will comprise 2 people, a Chairman and a President.

Worth reading
46Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 26 June 2026

Incoming appointee

1 item
Scheduled Appointment Date26 June 2026
Nakamura Yuichi (中村 雄一)
Previous positionSenior Managing Director, Head of Sales
New positionRepresentative Director and President
入社年 2009所有株式数 53,000 shares (as of 31 March 2026)

Departing officer

1 item
Nakamura Takato (中村 孝人)Next role stated
Former PositionRepresentative Director and President
New positionRepresentative director and chairman

“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.

Whether the incumbent will remain in office (whether they will retain their position)

Remains on the Board (Representative Director and Chairman)

Reason for change

The company is changing its Representative Directors to strengthen its management structure and ensure a smooth transition, with the aim of achieving further growth and enhancing corporate value over the medium to long term. In addition, from the perspective of improving flexibility in operating the company, the company’s representatives have been changed to a structure comprising 2 people, the Representative Director and Chairman and the Representative Director and President.

Details of organizational changes

The company’s representatives have been changed to a structure comprising 2 people, the Representative Director and Chairman and the Representative Director and President

Who is moving to which position
ItemDetails
Resolution date26 June 2026
Scheduled Appointment Date26 June 2026
Name of appointeeNakamura Yuichi (中村 雄一)
Appointee's new positionRepresentative Director and President
Appointee's previous positionSenior Managing Director, Head of Sales
Year the appointee joined the Company2009
Number of shares held by the appointee53,000 shares (as of 31 March 2026)
Name of departing officerNakamura Takato (中村 孝人)
Former position of departing officerRepresentative Director and President
New position of departing officerRepresentative director and chairman
Whether the incumbent will remain in officeRemains on the Board (Representative Director and Chairman)
Reason for changeThe company is changing its Representative Directors to strengthen its management structure and ensure a smooth transition, with the aim of achieving further growth and enhancing corporate value over the medium to long term. In addition, from the perspective of improving flexibility in operating the company, the company’s representatives have been changed to a structure comprising 2 people, the Representative Director and Chairman and the Representative Director and President.
Details of organizational changesThe company’s representatives have been changed to a structure comprising 2 people, the Representative Director and Chairman and the Representative Director and President
Items this document does not state (8)
Date of departureAppointee's date of birthReason for departureReasons for appointmentNumber of directors after the changeFiling as an independent officerChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To achieve further growth and enhance corporate value over the medium to long term, strengthen the management structure, ensure a smooth transition, and improve flexibility in operating the company.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Changes in Representative Directors | Kohjin Bio Co.,Ltd. (177A) timely disclosure | Komori